Breaking News

Thursday briefing

Photo of author

By [email protected]

EY wins first Dax audit client since Wirecard scandal

Roche’s phase IIb study of bracinizumab misses its primary endpoint, but suggests potential clinical benefit in early-stage Parkinson’s disease.

Leave a Comment